Bank of America’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-60,252
| Closed | -$2.04M | – | 8685 |
|
|
2021
Q2 | $2.04M | Sell |
60,252
-65,711
| -52% | -$1.67M | ﹤0.01% | 4296 |
|
|
2021
Q1 | $2.95M | Buy |
125,963
+70,386
| +127% | +$2.13M | ﹤0.01% | 3903 |
|
|
2020
Q4 | $1.6M | Sell |
55,577
-6,198
| -10% | -$156K | ﹤0.01% | 4131 |
|
|
2020
Q3 | $1.25M | Buy |
61,775
+21,398
| +53% | +$522K | ﹤0.01% | 4026 |
|
|
2020
Q2 | $1.21M | Buy |
40,377
+29,036
| +256% | +$1.05M | ﹤0.01% | 3992 |
|
|
2020
Q1 | $357K | Buy |
11,341
+5,665
| +100% | +$197K | ﹤0.01% | 4740 |
|
|
2019
Q4 | $268K | Sell |
5,676
-1,082
| -16% | -$31.2K | ﹤0.01% | 5438 |
|
|
2019
Q3 | $43K | Buy |
6,758
+512
| +8% | +$4.28K | ﹤0.01% | 6374 |
|
|
2019
Q2 | $76K | Buy |
6,246
+2,502
| +67% | +$27.9K | ﹤0.01% | 6124 |
|
|
2019
Q1 | $51K | Sell |
3,744
-569
| -13% | -$5.1K | ﹤0.01% | 6194 |
|
|
2018
Q4 | $17K | Buy |
4,313
+3,298
| +325% | +$19.9K | ﹤0.01% | 6529 |
|
|
2018
Q3 | $7K | Buy |
+1,015
| New | +$9.67K | ﹤0.01% | 6769 |
|
Bank of America's CNST Position: Q3 2021 in Review
Bank of America sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 60,252 shares — an estimated $2.04M sold.
Bank of America first reported a position in CNST in Q3 2018 and held it in 12 quarters. The position peaked at $2.95M in Q1 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.
- Bank of America reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
- Bank of America sold 60,252 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $2.04M.
- Bank of America first reported a position in Constellation Pharmaceuticals, Inc. in Q3 2018 and held it in 12 quarters.
- Bank of America's Constellation Pharmaceuticals, Inc. position peaked at $2.95M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.
Based on Bank of America's 13F filing for Q3 2021, filed 15 Nov 2021.